HK1256789A1
(en )
2019-10-04
Aptamer therapeutics useful in the treatment of complement-related disorders
HK1210495A1
(en )
2016-04-22
Aptamer therapeutics useful in the treatment of complement-related disorders
EP1957462A4
(en )
2010-09-15
Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies
PL1912650T3
(en )
2018-01-31
Use of flibanserin in the treatment of obesity
HK1170429A1
(en )
2013-03-01
Alpha aminoamide derivatives useful in the treatment of cognitive disorders
BRPI0809272A2
(en )
2014-10-14
BIARIL AND BIHETEROARIL COMPOUNDS IN THE TREATMENT OF IRON DISORDERS
IL205578A0
(en )
2010-11-30
Aldh-2 inhibitors in the treatment of psychiatric disorders
IL190969A0
(en )
2008-12-29
Pyrazoles useful in the treatment of inflammation
HK1146221A1
(en )
2011-05-20
Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
HK1134032A1
(en )
2010-04-16
New combination for use in the treatment of inflammatory disorders
GB2442365B
(en )
2010-01-20
Methods of determining compounds useful in the treatment of bipolar disorders
GB0710277D0
(en )
2007-07-11
Use of antivirals in the treatment of medical disorders
SI1727567T1
(en )
2013-11-29
Aptamer therapeutics useful in the treatment of complement-related disorders
GB0513413D0
(en )
2005-08-03
The treatment of inflammatory disorders and pain
ZA200904249B
(en )
2010-08-25
New combination for use in the treatment of inflammatory disorders
HK1125634A1
(en )
2009-08-14
Pharmaceutical for use in the treatment of ureterolithiasis
GB0502596D0
(en )
2005-03-16
The treatment of inflammatory disorders and pain
IL229577A0
(en )
2014-01-30
Novel aminoglycosides and uses thereof in the treatment of genetic disorders
GB0406016D0
(en )
2004-04-21
The treatment of inflammatory disorders
GB0406017D0
(en )
2004-04-21
The treatment of inflammatory disorders
GB0422880D0
(en )
2004-11-17
The treatment of inflammatory disorders
IL194370A0
(en )
2009-08-03
Novel aminoglycosides and uses thereof in the treatment of genetic disorders